Coloplast CEO looks forward to pivotal launch
The medtech company Coloplast has a number of important studies in the pipeline, and the its President and CEO Kristian Villumsen calls the launch of a new catheter platform absolutely crucial for the company's future continence operations.
BY ULRICH QUISTGAARD, TRANSLATED BY DANIEL PEDERSEN
Coloplast is launching several clinical trials around the New Year in both in the UK and Germany, including important studies testing a new digital ostomy solution that can warn users of leaks via a sensor, an implanted nerve stimulator against overactive bladder disorder and a new antibacterial catheter platform, as reported by Danish business daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
